Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  Childs: []
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
    value: Clinical group
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '614286'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '11998'
        Source: HGNC
      - Reference: '191170'
        Source: OMIM
      - Reference: TP53
        Source: ClinVar
      Name: tumor protein p53
      Symbol: TP53
  Label: Myelodysplastic syndrome
  ORPHAcode: '52688'
  ORPHApacketId: '52688'
  PURL: http://www.orpha.net/ORDO/Orphanet_52688
  Parents:
  - Parent:
    - Label: Myeloid hemopathy
      ORPHAcode: '171895'
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21708407[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21708407[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: Institut National du Cancer 2013[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7718765[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 18443215[PMID]_17345612[PMID]_National Cancer Institute[INST]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23572136[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7986716[PMID]_7819118[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7720834[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19411107[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 14555322[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: emedicine 2009[OTHER]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 27699872[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 27699872[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 28056392[PMID]
      ValMoy: no data
  TextSection:
    Contents: A group of myeloid hemopathies characterized by blood cytopenias marrow
      dysplasia and a high risk of progression to acute myeloid leukemia (AML).
    TextSectionType: Definition
  copyright: Orphanet (c) 2024
  creationDate: '2024-12-03 10:13:55'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
